India enjoys an important position in the global pharmaceuticals sector with a 20% share of generic medicines in supplies by volume. In addition, the Indian pharmaceutical sector industry supplies 62% percent of global demand for various vaccines, 40% of the generic market in the US, and 25% of all medicine in the UK.
India is the source of 60,000 generic brands across 60 therapeutic categories and manufactures more than 500 different Active Pharmaceutical Ingredients (APIs). The export of generic drugs is one of India's core strengths. The country's pharmaceutical exports stood at $24.44 billion in FY 20-21.
The industry has granted incentives totaling INR 21,940 Crore ($ $3 Mn).
100% Foreign Direct Investment (FDI) in pharmaceuticals in India is allowed under the automatic route for green-field pharma.
100% FDI in Drugs and Pharmaceuticals in India is allowed in brownfield pharma, wherein 74% FDI in the Pharmaceuticals Sector is permitted under the automatic route and after that through government approval.
Generics medicines exports share (global)
Exports worth (FY 21-22)
FDI (April 2021 - March 2022)
Largest vaccine producer in the world.
Largest manufacturers and exporters of generic medicines.
Indian Pharma Industry generates over $11 bn of trade surplus every year.
FDI in India Crossed 80 Billion Dollar Last Year: PM Modi
Indian Healthcare Sector Attracts Over USD 12 Billion in FDI: PM Modi
PM Modi pushes for Aatmanirbharta vision at CII Annual Meeting 2021
India must be aware of new FDI - Foreign Destructive Ideology. Says PM Modi.
FDI equity inflows into India cross $500 billion milestone